Libri di Charles B. Nemeroff | Libreria Cortina dal 1946
Novità Libri adottati nelle Università di Milano Tutti i libri corso per corso, esame per esame

Libri di Charles B. Nemeroff

Essentials of clinical psychopharmacology

Alan F. Schatzberg, Charles B. Nemeroff

editore: American Psychiatric Publishing

pagine: 880

Essentials of Psychopharmacology provides a synopsis and update of the most clinically relevant material included within its parent publication, The American Psychiatric Publishing Textbook of Psychopharmacology, a classic that has been hailed as indispensable to psychiatry residents and clinicians alike. This new third edition of the Essentials incorporates the latest research and treatment advances and presents key information in an accessible and easy-to-use manner. The chapter authors are among the foremost national authorities in their areas of expertise, and the content has been thoroughly referenced and meticulously edited for maximum utility. Among the features of this third edition are the following: * Commonsense organization that takes the reader through the various classes of psychotropic medications (with chapters focused on individual drugs in each class) to treatment using those drugs (with chapters addressing drug selection and therapeutic approaches to the treatment of patients with major psychiatric disorders).* Complete information on each drug's clinical pharmacology, pharmacokinetics, approved indications, dosages, side effects and toxicology, and drug-drug interactions.* Comprehensive coverage of the current psychotropic pharmacopoeia, including new chapters on the recently introduced antipsychotics asenapine, iloperidone, and lurasidone and updated chapters reflecting further accumulation of experience with other medications.* Extensive and thoroughly updated information on the use of psychotropic medications during pregnancy and lactation. Clinicians seeking a reliable reference and guide to the core knowledge base and practice of clinical psychopharmacology can do no better than this new edition of Essentials of Psychopharmacology.
155,00 147,25

Neurobiology of Psychiatric Disorders

Charles B. Nemeroff, Dick. F. Swaab
e altri

editore: Elsevier Science Ltd

pagine: 762

This new volume in the Handbook of Clinical Neurology presents a comprehensive review of the fundamental science and clinical treatment of psychiatric disorders. Advances in neuroscience have allowed for dramatic advances in the understanding of psychiatric disorders and treatment. Brain disorders, such as depression and schizophrenia, are the leading cause of disability worldwide. It is estimated that over 25% of the adult population in North America are diagnosed yearly with at least one mental disorder and similar results hold for Europe. Now that neurology and psychiatry agree that all mental disorders are in fact, "brain diseases," this volume provides a foundational introduction to the science defining these disorders and details best practices for psychiatric treatment. *Provides a comprehensive review of the scientific foundations of psychiatric disorders and psychiatric treatment *Includes detailed results from genetics, molecular biology, brain imaging, and neuropathological, immunological, epidemiological, metabolic, therapeutic and historical aspects of the major psychiatric disorders *A "must have reference and resource for neuroscientists, neurologists, psychiatrists, and clinical psychologists as well as all research scientists investigating disorders of the brain
220,00 209,00

Principles of Psychopharmacology for Mental Health Professionals

Charles B. Nemeroff, D. Jeffrey Newport
e altri

editore: John Wiley & Sons Inc

pagine: 408

Principles of Psychopharmacology for Mental Health Professionals addresses the current "split" model of mental health care, in which physicians provide pharmaco-therapy while non-prescribing practitioners oversee other services such as psychotherapy. Bringing these two areas together, this book familiarizes mental health professionals with the medications used to treat psychiatric disorders. Prepared by world-renowned psychopharmacologists and psychiatrists, this useful resource helps non-prescribing practitioners understand when and why a given medication is appropriate to use, when it is not indicated, and what potential side effects may occur. Also discussed are the appropriate times in therapy when a referral for a medication evaluation is indicated as well as how to broach this issue with the patient. Recognizing that there are almost always a number of medications from which to choose, the authors combine research outcomes with their extensive clinical experience to highlight the important considerations in selecting one medication over another. As an educational tool, the text encourages and supports clinicians who wish to increase patients' understanding of treatment. After an introduction and overview, chapters cover: Basics of psychopharmacology Attention-deficit hyperactivity disorder Mood disorders Sleep disorders Schizophrenia Cognitive disorders Anxiety disorders Personality disorders Substance use disorders Traumatic brain injury Eating disorders Side effects Every chapter includes diagnostic considerations, history of medication treatments, and emerging trends for each disease. Principles of Psychopharmacology for Mental Health Professionals lays out what psychotherapists and other mental health practitioners need to know about psychotropic medications, giving them and their patients an invaluable guide to the full array of treatments available.
73,00 69,35

The American Psychiatric Publishing Textbook of Psychopharmacology

Alan F. Schatzberg, Charles B. Nemeroff

editore: American Psychiatric Publishing

pagine: 1632

Its last edition hailed as "an essential volume for psychiatry residents as well as clinicians" (Journal of Psychiatric Practice), The American Psychiatric Publishing Textbook of Psychopharmacology is now updated to keep you abreast of the latest research and trends in the field. Covering both basic science and clinical practice, this new edition draws on the talents of 53 new contributors -- with the total increased from 139 to 158 -- to guarantee fresh, authoritative perspectives on advances in psychiatric drug therapy. Introductory chapters provide a theoretical grounding in clinical applications, with coverage ranging from neurotransmitters to clinical trial design. The "Classes of Psychiatric Treatment" section is a virtual pharmacopoeia, with chapters devoted to specific agents. It presents information by class of drug, and for each agent provides data on indications, side effects, interactions, and more -- including drugs likely to become available in the near future. Chapters in the "Clinical Psychobiology and Psychiatric Syndromes" section review the neurological underpinnings of specific disorders, providing a context for understanding psychopharmacological approaches to treatment. Coverage of those treatments encompasses state-of-the-art approaches to psychiatric disorders; specific patient populations, such as children and pregnant women; difficult-to-manage conditions like insomnia; and specific guidance on drug selection and prescription. Among the features of the fourth edition are the following * A new chapter on genomics and genetics covers basic methodologies and concepts to help you interpret the avalanche of data appearing in the human neuroscience literature.* Expanded chapters address newly approved agents, including the antidepressant desvenlafaxine, the antipsychotic paliperidone, and the anticonvulsant pregabalin.* A new chapter on the neurobiology of childhood disorders considers data relating to pervasive developmental disorders, psychoses, learning disorders, disruptive behavior disorder/ADHD, bipolar disorder, major depressive disorder, obsessive-compulsive disorder/Tourette's syndrome, PTSD, and pediatric anxiety disorders.* A new chapter on treatment of chronic pain syndromes discusses major classes of medications as they relate to pain management and covers prevalent disorders -- such as fibromyalgia and osteoarthritis -- in which this is a priority and for which evidence-based therapy is available.* A new, comprehensive review of ethical considerations in psychopharmacological treatment and research addresses such concerns as high-risk pharmacotherapy, long-acting medications, and off-label prescribing. Solidly established as an authoritative and comprehensive source, the new edition of this new edition of The American Psychiatric Publishing Textbook of Psychopharmacology is even more indispensable for clinicians and researchers alike.
280,00 266,00

Neuropsychopharmacology: The Fifth Generation of Progress

An Official Publication of the American College of Neuropsychopharmacology

Charles B. Nemeroff, Dennis Charney
e altri

editore: Lippincott Williams and Wilkins

pagine: 2080

Receive FREE On-Line Access through the American College of Neuropsychopharmacology website when you purchase the book! Simply return the card enclosed in the product shrink wrap. A password will be sent to you via e-mail. For a sample chapter, and to learn more about the ACNP, click here. Thoroughly updated and completely reorganized for a sharper clinical focus, the Fifth Edition of this world-renowned classic synthesizes the latest advances in basic neurobiology, biological psychiatry, and clinical neuropsychopharmacology. The book establishes a critical bridge connecting new discoveries in molecular and cellular biology, genetics, and neuroimaging with the etiology, diagnosis, and treatment of the full spectrum of neuropsychiatric disorders. Nine sections focus on specific groups of disorders - disorders of development; schizophrenia and related disorders; anxiety and stress disorders; affective disorders; Alzheimer's and other dementias; substance use disorders; impulsive and compulsive disorders; movement disorders and paroxysmal disorders; and chronobiology and sleep disorders. Each group of disorders is discussed in detail, including clinical course, genetics, neurobiology, neuroimaging, and current and emerging therapeutics. Four sections cover neurotransmitter and signal transduction, emerging methods in molecular biology and genetics, emerging imaging technologies and their psychiatric applications, and drug discovery and evaluation. Compatibility: BlackBerry[registered] OS 4.1 or Higher / iPhone/iPod Touch 2.0 or Higher /Palm OS 3.5 or higher / Palm Pre Classic / Symbian S60, 3rd edition (Nokia) / Windows Mobile[trademark] Pocket PC (all versions) / Windows Mobile Smartphone / Windows 98SE/2000/ME/XP/Vista/Tablet PC.
204,00 193,80

Inserire il codice per il download.

Inserire il codice per attivare il servizio.

Questo sito o gli strumenti terzi da questo utilizzati si avvalgono di cookie necessari al funzionamento ed utili alle finalità illustrate nella cookie policy.
Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie, consulta la cookie policy.
Chiudendo questo avviso, navigando in questa pagina, cliccando su un link o proseguendo la navigazione in altra maniera, acconsenti all'uso dei cookie.

Acconsento